GILD vs PFE — Key Metrics
| Metric | GILD (GILEAD SCIENCES INC) | PFE (PFIZER INC) |
|---|---|---|
| Price | 149.05 | 28.52 |
| Market Cap | 184.82 Billion | 162.55 Billion |
| P/E (TTM) | -57.33 | 37.53 |
| P/B (Quarterly) | 13.717 | 1.7 |
| P/S (TTM) | 6.07 | 2.55 |
| Net Profit Margin (TTM) | -10.6 | 6.8 |
| Gross Margin (TTM) | 79.6 | 73.2 |
| ROE (TTM) | -16.3 | 4.9 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
GILD · GILEAD SCIENCES INC
Outperform
PFE · PFIZER INC
Greatly Outperform
Recommendation Summary
Stock GILD is projected to outperform the market, stock PFE is projected to greatly outperform the market. Upfront Recommendation: PFE.
Financial Metrics
Prices delayed ~15 min
| GILD | Metrics | PFE |
|---|---|---|
| $149.05 | Price | $28.52 |
| — | Market Capitalization | — |
| 6.07 | Price to Sales | 2.55 |
| 14.28 | Price to FCF Ratio | 14.8 |
| 7.62 | Price to Gross Profit | 3.49 |
| 30.47 | Price to R&D | 14.71 |
| 13.25 | Price to Current Assets | 3.93 |